Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004341:Drug Evaluation; D005260:Female; D015248:Gemfibrozil; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010421:Pentanoic Acids / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D014631:Valerates; D015248:Gemfibrozil